Maxele Advisors, LLC
- SEC CIK
- 0002096567
- Latest filing
- Aug 14, 2026
JNJ holding history
Johnson & Johnson in every 13F filed by Maxele Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
JNJ overviewAll 13F holders of JNJFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,680
- Value
- $426.7K
- % of portfolio
- 0.3%
- Quarters held
- 10
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,680 | $426.7K | 0.3% | – | No prior filing | Holders |
| Q1 2026 | – | – | – | – | Not filed | Holders |
| Q4 2025 | 1,700 | $351.8K | 0.3% | +238+16.3% | Added | Holders |
| Q3 2025 | 1,462 | $271.1K | 0.2% | +3+0.2% | Added | Holders |
| Q2 2025 | 1,459 | $222.8K | 0.2% | +4+0.3% | Added | Holders |
| Q1 2025 | 1,455 | $241.3K | 0.2% | −36−2.4% | Reduced | Holders |
| Q4 2024 | 1,491 | $215.6K | 0.2% | – | No prior filing | Holders |
| Q4 2022 | – | – | – | – | Not filed | Holders |
| Q3 2022 | 2,045 | $334.1K | 0.6% | −15−0.7% | Reduced | Holders |
| Q2 2022 | 2,060 | $365.7K | 0.6% | −150−6.8% | Reduced | Holders |
| Q1 2022 | 2,210 | $391.7K | 0.5% | −25−1.1% | Reduced | Holders |
| Q4 2021 | 2,235 | $382.3K | 0.4% | – | No prior filing | Holders |